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Nutrient‐sensitized screening for new drug development against Ischemic Kidney
Injury
Seiji Kishi and Toshio Doi
Department of Nephrology, Tokushima University Hospital, Tokushima, Japan
SUMMARY
Acute kidney injury（AKI）is a big clinical problem. In addition to high mortality rate, AKI is
a potent risk factor of end-stage kidney disease. Ischemia reperfusion injury（IRI）is the leading
cause of AKI and we have no specific treatment options to treat AKI. Shifting energy metabolism
from mitochondrial respiration to glycolysis may offer a novel therapy against ischemic organ
injury. Based on this theory, Meclizine, first-generation antihistamine used for motion sickness
and vertigo, was identified in a novel chemical screen. Kidney tubular injury after ischemia
reperfusion was significantly decreased in meclizine treated mice compared with the vehicle
treated mice（１００mg/kg of meclizine, １７hours prior to ischemia）. Meclizine treated kidney
showed reduced inflammation, oxidative stress and mitochondrial fragmentation after IRI.
Meclizine pretreatment reduced mitochondrial oxygen consumption. Reduced cell death and
cytochrome c release was found in kidney tubular epithelial cells. Metabolic profiling revealed
that Meclizine caused rapid accumulation of cellular phosphoethanolamine（PEtn）. PEtn inhibits
mitochondrial respiration and is an intermediate in phosphatidylethanolamine biosynthesis
pathway（Kennedy pathway）. In conclusion, Meclizine, or a derivative, is a candidate drug to
minimize AKI risk and Kennedy pathway can be a novel therapeutic target for ischiemic kidney
injury.
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